Shiva Kalidindi

A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

Allison August, Husain Attarwala, Sunny Himansu et al. · Nature Medicine · 2021 · 165 citations · Full text

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials

Brandon Essink, Laurence Chu, William Seger et al. · The Lancet Infectious Diseases · 2023 · 129 citations

Vaccination, Vaccine Safety, Vaccine Development +8

Safety and Immunogenicity of a Messenger RNA–Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial

Carlos Fierro, Daniel C. Brune, Marian Shaw et al. · The Journal of Infectious Diseases · 2024 · 45 citations · Full text

Safety and Immunogenicity of an mRNA-Based hMPV/PIV3 Combination Vaccine in Seropositive Children

Sabine Schnyder Ghamloush, Brandon Essink, Bo Hu et al. · PEDIATRICS · 2024 · 29 citations · Full text

2754. Phase 1 Trial of an mRNA-Based Combination Vaccine Against hMPV and PIV3

Christine A. Shaw, Heather Lee, Conor Knightly et al. · Open Forum Infectious Diseases · 2019 · 21 citations · Full text

Vaccination, Vaccinology, Piv3 Neutralization Titers +15